Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

Affiliations

• ¹ Myeloid Malignancies Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
• ² Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
• ³ Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ⁴ 1] Johns Hopkins University School of Medicine, Baltimore, MD, USA [2] Cancer Immunology Experimental Medicine, Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland.
• ⁵ Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
• ⁶ Center for Leukemia and the Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.